<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28100779</article-id>
<article-id pub-id-type="pmc">5336181</article-id>
<article-id pub-id-type="publisher-id">M116.768077</article-id>
<article-id pub-id-type="doi">10.1074/jbc.M116.768077</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Membrane Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Intramembrane Proteolysis of Astrotactins<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"></inline-graphic></sup></xref></article-title>
<alt-title alt-title-type="short">Intramembrane Proteolysis of Astrotactins</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="author-notes" rid="FN3">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smallwood</surname>
<given-names>Philip M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nathans</surname>
<given-names>Jeremy</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>¶</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1">From the Departments of <label>‡</label>Molecular Biology and Genetics, </aff>
<aff id="aff2"><label>§</label>Neuroscience, and </aff>
<aff id="aff3"><label>¶</label>Ophthalmology, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>2</label> To whom correspondence should be addressed: <addr-line>805 PCTB, 725 N. Wolfe St., Johns Hopkins University School of Medicine, Baltimore, MD 21205.</addr-line> Tel.: <phone>410-955-4679</phone>; Fax: <fax>410-614-0827</fax>; E-mail: <email>jnathans@jhmi.edu</email>.</corresp>
<fn fn-type="present-address" id="FN3">
<label>1</label>
<p>Present address: Dept. of Dermatology, University of Wisconsin-Madison, 1300 University Ave., Madison, WI 53706.</p>
</fn>
<fn fn-type="edited-by">
<p>Edited by Paul E. Fraser</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>24</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>1</month>
<year>2017</year>
</pub-date>
<volume>292</volume>
<issue>8</issue>
<fpage>3506</fpage>
<lpage>3516</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>1</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc00817003506.pdf"></self-uri>
<abstract>
<p>Astrotactins are vertebrate-specific membrane proteins implicated in neuron-glia interactions during central nervous system development and in hair follicle polarity during skin development. By studying epitope-tagged derivatives of mouse astrotactin-2 (Astn2) produced in transfected cells, we determined that the amino and carboxyl termini reside in the extracellular space and are initially linked by two transmembrane segments and a single cytoplasmic domain. We further show that Astn2 undergoes proteolytic cleavage in the second transmembrane domain (TM2) and that a disulfide bond holds the resulting two fragments together. Recombinant Astn1 also undergoes TM2 cleavage, as does Astn2 isolated from mouse cerebellum. Astn2 intramembrane proteolysis is insensitive to replacement of TM2 by the transmembrane domain of CD74 or by 21 alanines. However, replacement of TM2 by the transmembrane domain of CD4, the asialoglycoprotein receptor, or the transferrin receptor eliminates intramembrane proteolysis, as does leucine substitution of residues that overlap or are immediately upstream of the cleavage site. Replacement of the transmembrane domain of CD74 or the asialoglycoprotein receptor with Astn2 TM2 leads to the appearance of a carboxyl-terminal fragment consistent with intramembrane proteolysis. These experiments define a highly unusual transmembrane topology for the astrotactins, reveal intramembrane proteolysis as a feature of astrotactin maturation, and constrain the substrate sequences that are permissive for cleavage of one type 2 transmembrane segment.</p>
</abstract>
<kwd-group>
<kwd>intramembrane proteolysis</kwd>
<kwd>membrane protein</kwd>
<kwd>protein processing</kwd>
<kwd>protein sequence</kwd>
<kwd>transmembrane domain</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>Howard Hughes Medical Institute
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000011</named-content></funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>